ABSTRACT
The latest genome-wide association studies (GWAS) comprising 20,165 acne cases and 595,231 controls have successfully identified 42 genomic regions associated with increased risk of acne. Yet, it remains unclear the extent to which these individual acne susceptibility loci contribute to other disorders. To begin to identify shared and unique biology underlying acne pathogenesis, we conducted phenome-wide association (PheWAS) of the 42 acne loci across 110 phenotypes with large-scale, well-powered GWAS results that broadly span autoimmune, endocrine, psychiatric, cardiovascular, dermatologic conditions, and cancer, as well as serum and urine biomarkers. Much of the acne loci did not share GWAS signals with any of 110 phenotypes, suggesting that there may be acne-specific biology in these genomic regions. Conversely, we also identified shared genetic effects at several loci with testosterone, sex hormone binding globulin (SHBG), non-albumin protein levels, liver enzymes (AST, AST/ALT ratio), and blood cell phenotypes (MCV, MCH, eosinophil count), some of which recapitulate known acne pathophysiology. Overall, this work highlights shared and unique genetic effects of individual acne GWAS loci via phenome-wide investigation. All GWAS summary statistics used herein and code to reproduce bioinformatic data analyses are publicly available.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the UCLA-Caltech Medical Scientist Training Program (T32GM008042).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos